FDA Clears 1st Drug Interchangeable With AbbVie's Humira
The U.S. Food and Drug Administration has given Boehringer Ingelheim the green light to launch an interchangeable biosimilar to AbbVie Inc.'s blockbuster immunosuppressant Humira....To view the full article, register now.
Already a subscriber? Click here to view full article